Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Pregnant women with asthma can be more confident about some medicines

Pregnant women with asthma can be more confident about some medicines

December 04, 2008

Budesonide sprays can be regarded as safe for pregnancy - other asthma drugs have not been as well studied though

Women can usually keep using the same asthma drugs they were using before they got pregnant. Budesonide sprays are the best studied and can be regarded as safe. More trials of other essential medicines are necessary however. According to the German Institute for Quality and Efficiency in Health Care (IQWiG), more data from trials could reassure women who worry about the safety of their drugs during pregnancy. The Institute has reviewed the evidence on asthma in pregnancy and published information for pregnant women on its website, www.informedhealthonline.org.




More trials on medications in pregnancy are necessary

Pregnant women with asthma want to know whether it is possible for the medications they take to harm their baby - and they want to know what they can do to reduce the risks of their asthma for their unborn baby. "Regulations ensure that drug product information lists unanswered safety questions about use in pregnancy. That can be somewhat misleading and cause anxiety. Imprecise research results in medical journals sometimes lead to worrying media reports. Some recent reports in Germany even wrongly suggested that asthma drugs could cause a malformation rate of almost 10%," according to the Institute's Director, Professor Peter Sawicki.

Essential medicines are generally not researched enough in pregnancy, and so remain associated with a lot of uncertainty. This can be a big problem for pregnant women. Professor Sawicki said: "In some countries large birth registers provide information on medication use in pregnancy and malformations in babies. But that cannot replace the more precise assessment from trials. There need to more trials that pregnant women can participate in. We need more reliable knowledge about the effects of essential medicines in pregnancy."

Avoiding asthma attacks is critical in pregnancy

Good self-management can keep asthma under control. "For women with asthma who have not been actively self-managing their asthma, pregnancy is a good time to start," Professor Sawicki said. "Good asthma control prevents asthma attacks, and that ensures that the baby's oxygen supply is not interrupted. It lowers the risk of needing to be hospitalised with an asthma attack."

Women with asthma can usually keep using the same medications during pregnancy that helped them before. Pregnancy is not a good time to try out treatments where little is known about the effects on unborn babies. Most asthma medications have not been studied in trials that include pregnant women. However, budesonide sprays have been studied enough: women can be confident about budesonide's safety for pregnancy. Budesonide is a steroid.

Quitting smoking reduces the risk of a baby developing asthma

Quitting smoking is the best thing a woman can do to protect her baby from developing asthma. "Researchers are studying a variety of options for preventing asthma in babies, including diet and probiotics. Quitting smoking is the only effective prevention that has been demonstrated to date", according to Professor Sawicki. This also counts for the father: when parents quit smoking, they can reduce the risk that their child will later develop asthma or allergies.

Institute for Quality and Efficiency in Health Care



Related Budesonide Current Events and Budesonide News Articles Budesonide Current Events and Budesonide News RSS Budesonide Current Events and Budesonide News RSS
Budesonide is not beneficial for the treatment of diarrhea in metastatic melanoma patients
Patients with stage III or IV melanoma taking ipilimumab and the oral steroid budesonide to reduce side effects did not have less diarrhea, a known side effect of ipilimumab.

Asthma drugs need to be maintained for continued benefit
Children whose asthma improved while taking steroid drugs for several years did not see those improvements continue after stopping the drugs, new results from a comprehensive childhood asthma study show.

Pregnant women with asthma can be more confident about some medicines
Women can usually keep using the same asthma drugs they were using before they got pregnant. Budesonide sprays are the best studied and can be regarded as safe.

New patient satisfaction study with budesonide/formoterol combination therapy
A new open-label study evaluated patient satisfaction with budesonide/formoterol combination therapy and fluticasone/salmeterol combination therapy.

Some common treatments for sinus infections may not be effective
A comparison of common treatments for acute sinusitis that included an antibiotic and a topical steroid found neither more effective than placebo, according to a study in the December 5 issue of JAMA.

Literature review highlights options for self-management of asthma exacerbations
An extensive literature review undertaken by the Woolcock Institute of Medical Research has examined the pharmacological strategies for self-management of asthma exacerbations in adults, including those using inhaled corticosteroid/long-acting รข2-agonist (ICS/LABA) therapy.

Focus on lung cancer: How to prevent and treat it
Since smoking became popular in America in the 1930s, lung cancer rates have continued to climb.

Inhaled Steroids Could Be New Option For Treating Mild Asthma (p 1071)
Results of a large international study in this week's issue of THE LANCET provide strong evidence that inhaled steroids could substantially reduce illness associated with mild asthma. Previous research has not established whether steroids could be effective in controlling mild asthma, mainly because people with moderate disease symptoms were included in earlier studies. Romain Pauwels from Ghent's University Hospital, Belgium, and colleagues did a randomised clinical trial in over 7200 patients age 5-66 years from 32 countries to assess the effects of the steroid budesonide in patients with mild asthma. Asthma onset had to be recent (within two years) and patients had not received previous

Survey highlights 'crucial' safety issues in rhinitis treatment, particularly in children
Children may be at risk of receiving rhinitis treatment that suppresses growth - but the problem can be avoided through careful selection of treatment. This was the overwhelming message emerging from a recent nationwide survey of ENT specialists. According to the findings, the vast majority (91%) of specialists surveyed said they considered growth suppression the most important potential adverse drug reaction associated with nasal steroids. And a similar proportion (88%) said the selection of a nasal steroid for a child should be based on its low potential for adverse effects on growth. The use of systemic steroids has been linked to growth suppression but the danger is not necessarily avoid
More Budesonide Current Events and Budesonide News Articles
  Formoterol-budesonide inhaler offers advantage; vs. Budesonide alone.(Clinical Rounds)(Brief Article): An article from: Internal Medicine News
by Steve Perlstein (Author)

This digital document is an article from Internal Medicine News, published by International Medical News Group on August 1, 2003. The length of the article is 1334 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Formoterol-budesonide inhaler offers advantage; vs. Budesonide alone.(Clinical Rounds)(Brief Article)
Author: Steve Perlstein
Publication: Internal Medicine News (Magazine/Journal)
Date: August 1, 2003
Publisher: International Medical News Group
Volume: 36 Issue: 15 Page: 20(1)

Article Type: Brief Article

Distributed by Thomson...

  FDA warns compounders of inhaled budesonide.(News): An article from: Family Practice News
by Elizabeth Mechcatie (Author)

This digital document is an article from Family Practice News, published by Thomson Gale on September 15, 2006. The length of the article is 667 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: FDA warns compounders of inhaled budesonide.(News)
Author: Elizabeth Mechcatie
Publication: Family Practice News (Magazine/Journal)
Date: September 15, 2006
Publisher: Thomson Gale
Volume: 36 Issue: 18 Page: 8(1)

Distributed by Thomson...

  Long-Term budesonide use by asthmatic children does not suppress HPA axis function. (Children Treated for 3 Years).(hypothalamic-pituitary-adrenal axis): An article from: Pediatric News
by Mitchel L. Zoler (Author)

This digital document is an article from Pediatric News, published by International Medical News Group on May 1, 2002. The length of the article is 421 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Long-Term budesonide use by asthmatic children does not suppress HPA axis function. (Children Treated for 3 Years).(hypothalamic-pituitary-adrenal axis)
Author: Mitchel L. Zoler
Publication: Pediatric News (Magazine/Journal)
Date: May 1, 2002
Publisher: International Medical News Group
Volume: 36 Issue: 5 Page: 44(1)

Distributed by Thomson...

  Nebulised Budesonide Therapy in Asthma: A Scientific and Practical Review
by William Jackson (Author)



  More budesonide absorbed with a dry powder inhaler. (Impacts Long-Term Therapy).(Brief Article): An article from: Pediatric News
by Kerri Wachter (Author)

This digital document is an article from Pediatric News, published by International Medical News Group on February 1, 2003. The length of the article is 331 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: More budesonide absorbed with a dry powder inhaler. (Impacts Long-Term Therapy).(Brief Article)
Author: Kerri Wachter
Publication: Pediatric News (Magazine/Journal)
Date: February 1, 2003
Publisher: International Medical News Group
Volume: 37 Issue: 2 Page: 5(1)

Article Type: Brief Article

Distributed by Thomson...

Budesonide - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References

Budesonide - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
by ICON Health Publications (Author)

In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading." Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and printing.This book was created for medical professionals, students, and members of the general public who want to conduct medical research using the most advanced tools available and spending the least amount of time doing so.

  Early inhaled steroids beneficial in mild asthma: budesonide cut risk of severe exacerbations by 44% in large 'real-world' clinical trial. (Cost-Effective ... An article from: Internal Medicine News
by Miriam E. Tucker (Author)

This digital document is an article from Internal Medicine News, published by International Medical News Group on December 15, 2002. The length of the article is 922 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Early inhaled steroids beneficial in mild asthma: budesonide cut risk of severe exacerbations by 44% in large 'real-world' clinical trial. (Cost-Effective Intervention).
Author: Miriam E. Tucker
Publication: Internal Medicine News (Magazine/Journal)
Date: December 15, 2002
Publisher: International Medical News Group
Volume: 35 Issue: 24 Page:...

  Asthma therapy safe for kids over long term: budesonide inhalation suspension.(Children's Health): An article from: Family Practice News
by Kerri Wachter (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on March 15, 2004. The length of the article is 429 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Asthma therapy safe for kids over long term: budesonide inhalation suspension.(Children's Health)
Author: Kerri Wachter
Publication: Family Practice News (Magazine/Journal)
Date: March 15, 2004
Publisher: International Medical News Group
Volume: 34 Issue: 6 Page: 68(1)

Distributed by Thomson...

  Daily budesonide, formoterol works for asthma.(Clinical Rounds)(Clinical report): An article from: Pediatric News
by Robert Finn (Author)

This digital document is an article from Pediatric News, published by Thomson Gale on September 1, 2007. The length of the article is 461 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Daily budesonide, formoterol works for asthma.(Clinical Rounds)(Clinical report)
Author: Robert Finn
Publication: Pediatric News (Magazine/Journal)
Date: September 1, 2007
Publisher: Thomson Gale
Volume: 41 Issue: 9 Page: 55(1)

Article Type: Clinical report

Distributed by Thomson...

  Budesonide therapy benefits Crohn's, spares bones. (Spectacular Reduction in Bone Loss).: An article from: Family Practice News
by Bruce Jancin (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on January 15, 2003. The length of the article is 573 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Budesonide therapy benefits Crohn's, spares bones. (Spectacular Reduction in Bone Loss).
Author: Bruce Jancin
Publication: Family Practice News (Magazine/Journal)
Date: January 15, 2003
Publisher: International Medical News Group
Volume: 33 Issue: 2 Page: 26(1)

Distributed by Thomson...

© 2009 BrightSurf.com